yep melbs is for research only now, they did it to knock cash burn on head, the summary doesn't do the report justice, good read, basically spells out the entire game plan.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
